Jump to content

25H-NBOMe: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Citation bot (talk | contribs)
Add: title. Changed bare reference to CS1/2. | Use this bot. Report bugs. | Suggested by Abductive | Category:Drugs not assigned an ATC code | #UCB_Category 843/2241
→‎Legality: CS1 errors: invisible characters
Line 39: Line 39:


===Sweden===
===Sweden===
[[Riksdag|The Riksdag]] added 25H-NBOMe to [[:sv:Narkotikastrafflagen|Narcotic Drugs Punishments Act]] under ''swedish schedule I'' (''"substances, plant materials and fungi which normally do not have medical use"'') as of August 1, 2013, published by [[Medical Products Agency (Sweden)|Medical Products Agency (MPA)]] in regulation ''LVFS 2013:15'' listed as '''25H-NBOMe''', and '''2-(2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin'''.<ref>{{Cite web|url=https://lakemedelsverket.se/upload/lvfs/LVFS_2013-15.pdf|title = Läkemedelsverkets föreskrifter - LVFS och HSLF‍-‍FS &#124; Läkemedelsverket / Swedish Medical Products Agency}}</ref>
[[Riksdag|The Riksdag]] added 25H-NBOMe to [[:sv:Narkotikastrafflagen|Narcotic Drugs Punishments Act]] under ''swedish schedule I'' (''"substances, plant materials and fungi which normally do not have medical use"'') as of August 1, 2013, published by [[Medical Products Agency (Sweden)|Medical Products Agency (MPA)]] in regulation ''LVFS 2013:15'' listed as '''25H-NBOMe''', and '''2-(2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin'''.<ref>{{Cite web|title=Läkemedelsverkets föreskrifter - LVFS och HSLF-FS;Läkemedelsverket/Swedish Medical Products Agency|url=https://lakemedelsverket.se/upload/lvfs/LVFS_2013-15.pdf|url-status=live}}</ref>


===United Kingdom===
===United Kingdom===

Revision as of 18:52, 12 July 2021

25H-NBOMe
Clinical data
ATC code
  • none
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class A
Identifiers
  • 2-(2,5-Dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC18H23NO3
Molar mass301.386 g·mol−1
3D model (JSmol)
  • COC1=CC(=C(C=C1)OC)CCNCC2=CC=CC=C2OC
  • InChI=1S/C18H23NO3/c1-20-16-8-9-18(22-3)14(12-16)10-11-19-13-15-6-4-5-7-17(15)21-2/h4-9,12,19H,10-11,13H2,1-3H3
  • Key:RMLXCDMTGWSEOU-UHFFFAOYSA-N

25H-NBOMe (NBOMe-2C-H) is a derivative of the phenethylamine hallucinogen 2C-H, which acts as a highly potent partial agonist for the human 5-HT2A receptor.[1]

Legality

Sweden

The Riksdag added 25H-NBOMe to Narcotic Drugs Punishments Act under swedish schedule I ("substances, plant materials and fungi which normally do not have medical use") as of August 1, 2013, published by Medical Products Agency (MPA) in regulation LVFS 2013:15 listed as 25H-NBOMe, and 2-(2,5-dimetoxifenyl)-N-(2-metoxibensyl)etanamin.[2]

United Kingdom

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[3]

See also

References

  1. ^ https://bitnest.netfirms.com/external.php?id=%257DbxUaPRU%2505%255CG%252B%2527%252AFQ%2502%2518%2508U%250ATv[permanent dead link]
  2. ^ "Läkemedelsverkets föreskrifter - LVFS och HSLF-FS;Läkemedelsverket/Swedish Medical Products Agency" (PDF).{{cite web}}: CS1 maint: url-status (link)
  3. ^ "The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014". UK Statutory Instruments 2014 No. 1106. www.legislation.gov.uk.